Phylogica Limited is an Australia-based peptide drug discovery company. The Company's principal activity is drug discovery research and development, utilizing the Company's Phylomer peptide libraries and screening capabilities. The Company offers peptide discovery services to pharmaceutical companies. The Company's Phylomer libraries contain peptides that represent a source of biologically active drug leads for a range of intracellular and extracellular disease targets. The Phylomer libraries are based on expressed sequences of protein fragments that are encoded by the natural genes of evolutionary diverse microbes. These peptides, which are known as Phylomer peptides, consist of 15 to 50 amino acids. Its Phylomer libraries are in various phage display and yeast-two-hybrid formats, as well as in mammalian expression vectors for phenotypic screening. Dynamic Microbials Limited is a subsidiary of the Company.